Genius Sports stock has been absolutely hammered this year, but investors may be missing the prediction markets growth ...

After a trailing three-year return of 97%, investors are ready for this streaming platform to have another impressive showing ...

Amicus Therapeutics targets rare genetic diseases with proprietary therapies and a pipeline of treatments for underserved ...

Rivian and Lucid are both start-ups attempting to build EV companies, but one is executing better than the other.

Look, the S&P 500 ( ^GSPC +0.80%) is great. Buying the Vanguard S&P 500 ETF and forgetting about it for 30 years is a ...

Amazon's ( AMZN +3.47%) stock is starting to regain some momentum, up 50% over the past year. That comes after its share ...

DigitalBridge Group operates a global portfolio of digital infrastructure assets spanning data centers, fiber networks, and ...

Nvidia stock has soared since the AI boom began. Here's what investors need to know about the bull and bear cases for this AI ...

As is the case with most initial public offerings, the bulk of any SpaceX shares sold by investment bankers directly will go ...

Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.

Expense ratios, sector focus, and portfolio size set these two small-cap growth ETFs apart for investors weighing ...

Polkadot ( DOT +0.67%) is a network of specialized blockchains that share security and speak natively to one another, and it ...